1. Parkinson's disease: Prevalence, diagnosis and impact;Wong;Health Rep.,2014
2. C. Lachance, C. Spry, D. MacDougall, CADTH Rapid Response Reports, Deep Brain Stimulation for Parkinson’s Disease: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines, Canadian Agency for Drugs and Technologies in Health. Copyright © 2018 Canadian Agency for Drugs and Technologies in Health., Ottawa (ON), 2018.
3. Adverse events in deep brain stimulation: A retrospective long-term analysis of neurological, psychiatric and other occurrences;Buhmann;PLoS One,2017
4. Complications of Subthalamic Nucleus Stimulation in Parkinson's Disease;Umemura;Neurol. Med. Chir.,2011
5. Psychosis from subthalamic nucleus deep brain stimulator lesion effect;Widge;Surg. Neurol. Int.,2013